News

58.5% of an infant’s microbiota composition is transferred by their mother.

Investigators see a potential new approach to therapeutic development for C diff.

One of the most significant recommendations is for all adults to be tested for the virus at least once in their lifetime.

Nasal administration of the fully human anti-CD3 monoclonal antibody Foralumab modulated T cell inflammatory responses in COVID-19.

The companies, Apotex and Pharmedica, are doing this action due to concerns of sterility of the products.

A healthcare worker and a patient with HIV concomitantly provide important clinical considerations.

The congressional bill has been on Capitol Hill for over 2 years now, and the interested stakeholders are continuing their lobbying efforts to get it passed.

Enteric pathogens increase C difficile virulence by providing amino acids that shape the metabolic environment in the gut.

Use of early COVID-19 treatments did not reduce the risk of hospitalization or death, but did reduce long COVID symptoms after 3 months.

Children were hospitalized the most during the Omicron variant, but disease outcomes were the least severe during this variant period.

The hepatitis B vaccine (Recombinant), Adjuvanted (Heplisav-B) is approved in adults 18 years of age and older, and the vaccine’s developer, Dynavax, is working towards finding potential commercial partners for Great Britain.

The most common reasons parents cited for hiding a child’s COVID-19 infection included an inability to stay home from work and wanting to make decisions about their child’s health without outside input from authorities.

“HIV reservoir dynamics are driven by local inflammation and gut dysbiosis,” the investigators concluded.

The TRUNCATE-TB trial demonstrated 8 week regimen with bedaquiline and linezolid for rifampin-susceptible TB noninferior to standard 6-month treatment.

A young woman who dealt with reoccurring Clostridioides difficile (CDI) in a short amount of time recounts her experience and how getting into a clinical trial made the difference in resolving her condition and getting her back to good health and her family.

The therapy, bepirovirsen, is an antisense oligonucleotide that targets all Hepatitis B (HBV) messenger RNAs, and the company is hoping it will become a functional cure.

In the 12-month period following COVID-19 infection, long COVID patients had an excess death rate of 16.4 per 1000 individuals.

From concerns of Guillain-Barré syndrome to the gut microbiota's effect on COVID-19 infection severity, these were the week's top stories.

Periods of COVID-19 reinfection correlated with the circulation of new variants, as well as with time since first infection.

A single dose of pegylated lambda-interferon delivered within a week of the start of COVID-19 symptoms appears to significantly reduce the likelihood that a patient will end up hospitalized from the disease.

Gut microbial abundance was observed to be independent of age and influenced COVID-19 spike IgG levels.

Primary care physicians and advanced practice providers are responsible for the majority of people seeking medical care in the United States, yet there is a gap in discussing sexual health for those who are at risk of HIV or other sexually-transmitted diseases.

A single oral dose of azithromycin reduced the risk of maternal sepsis or death by 33% in women who delivered vaginally.

A recent animal study adds urgency to the fight against Clostridioides difficile infection, finding that the bacterium may be driving some colorectal cancers, which have risen among people younger than 50.

Based on the data presented today, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) believed the benefits outweighed the safety concerns.

The omega-3 fatty acids EPA and DHA may protect against COVID-19 by reducing inflammation.

Antimicrobial stewardship programs can protect drugs listed on the WHO Watch List, but the benefits are also dependent on countries' income level.

Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).